Error! You must have javascript enabled to use this form. Please enable Javascript in your browser. Global Factor XIII Deficiency Treatment Market Projected to Experience Major Revenue Boost During the Period 2018-2028 The prophylactic factor XIII deficiency treatment is mainly used to prevent bleeding in the brain. View full press release Your Name: Your Email: To Email: To BCC: Subject: Comments: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send